503 related articles for article (PubMed ID: 9192894)
1. Evolution of high mutation rates in experimental populations of E. coli.
Sniegowski PD; Gerrish PJ; Lenski RE
Nature; 1997 Jun; 387(6634):703-5. PubMed ID: 9192894
[TBL] [Abstract][Full Text] [Related]
2. Role of mutator alleles in adaptive evolution.
Taddei F; Radman M; Maynard-Smith J; Toupance B; Gouyon PH; Godelle B
Nature; 1997 Jun; 387(6634):700-2. PubMed ID: 9192893
[TBL] [Abstract][Full Text] [Related]
3. [Impact of mutation rate on the adaptation of gut bacteria].
Giraud A; Fons M; Taddei F
J Soc Biol; 2003; 197(4):389-96. PubMed ID: 15005521
[TBL] [Abstract][Full Text] [Related]
4. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
5. Coevolution with viruses drives the evolution of bacterial mutation rates.
Pal C; Maciá MD; Oliver A; Schachar I; Buckling A
Nature; 2007 Dec; 450(7172):1079-81. PubMed ID: 18059461
[TBL] [Abstract][Full Text] [Related]
6. Rates of DNA sequence evolution in experimental populations of Escherichia coli during 20,000 generations.
Lenski RE; Winkworth CL; Riley MA
J Mol Evol; 2003 Apr; 56(4):498-508. PubMed ID: 12664169
[TBL] [Abstract][Full Text] [Related]
7. Comparative genome sequencing of Escherichia coli allows observation of bacterial evolution on a laboratory timescale.
Herring CD; Raghunathan A; Honisch C; Patel T; Applebee MK; Joyce AR; Albert TJ; Blattner FR; van den Boom D; Cantor CR; Palsson BØ
Nat Genet; 2006 Dec; 38(12):1406-12. PubMed ID: 17086184
[TBL] [Abstract][Full Text] [Related]
8. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut.
Giraud A; Matic I; Tenaillon O; Clara A; Radman M; Fons M; Taddei F
Science; 2001 Mar; 291(5513):2606-8. PubMed ID: 11283373
[TBL] [Abstract][Full Text] [Related]
9. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
[TBL] [Abstract][Full Text] [Related]
10. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
[TBL] [Abstract][Full Text] [Related]
11. Stress-directed adaptive mutations and evolution.
Wright BE
Mol Microbiol; 2004 May; 52(3):643-50. PubMed ID: 15101972
[TBL] [Abstract][Full Text] [Related]
12. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
[TBL] [Abstract][Full Text] [Related]
13. Ploidy controls the success of mutators and nature of mutations during budding yeast evolution.
Thompson DA; Desai MM; Murray AW
Curr Biol; 2006 Aug; 16(16):1581-90. PubMed ID: 16920619
[TBL] [Abstract][Full Text] [Related]
14. Evolution of mutation rates in hypermutable populations of
Singh T; Hyun M; Sniegowski P
Biol Lett; 2017 Mar; 13(3):. PubMed ID: 28250208
[TBL] [Abstract][Full Text] [Related]
15. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
[TBL] [Abstract][Full Text] [Related]
16. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
Mammeri H; Van De Loo M; Poirel L; Martinez-Martinez L; Nordmann P
Antimicrob Agents Chemother; 2005 Jan; 49(1):71-6. PubMed ID: 15616277
[TBL] [Abstract][Full Text] [Related]
17. High deleterious genomic mutation rate in stationary phase of Escherichia coli.
Loewe L; Textor V; Scherer S
Science; 2003 Nov; 302(5650):1558-60. PubMed ID: 14645846
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of onset of quinolone-resistant mutants in E. coli strains].
Matinca D; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):169-70. PubMed ID: 15341335
[No Abstract] [Full Text] [Related]
19. Limits to adaptation in asexual populations.
de Visser JA; Rozen DE
J Evol Biol; 2005 Jul; 18(4):779-88. PubMed ID: 16033549
[TBL] [Abstract][Full Text] [Related]
20. Types of spontaneous nalidixic acid resistant mutants of Escherichia coli.
Kumar S
Indian J Exp Biol; 1980 Apr; 18(4):341-3. PubMed ID: 6995285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
